The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploring multidisciplinary practice patterns in the management of muscle invasive bladder cancer (MIBC) across the U.S. and Canada in 2015.
 
Lauren Christine Harshman
Consulting or Advisory Role - Bristol-Myers Squibb; Dendreon; Medivation/Astellas; NCCN; Pfizer; PlatformQ Health
Research Funding - Bayer; Medivation/Astellas
 
Matthew Kaag
No Relationships to Disclose
 
Jason A. Efstathiou
Consulting or Advisory Role - Medivation/Astellas
 
Andrea B. Apolo
No Relationships to Disclose
 
Jean H. Hoffman-Censits
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
Research Funding - Sanofi
 
Walter Michael Stadler
Honoraria - Bayer; CVS Caremark; Johnson & Johnson; medpacto; Merck; Sotio
Consulting or Advisory Role - Bayer; CVS Caremark; Johnson & Johnson; medpacto; Merck; Sotio
Research Funding - Active Biotech (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst)
Other Relationship - UpToDate
 
Evan Y. Yu
Honoraria - Amgen; Bayer; Dendreon; Janssen; Medivation; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; Genentech/Roche; Janssen; Medivation; Merck; Sanofi; Seagen; Tolmar
Research Funding - Agensys (Inst); Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Genentech/Roche (Inst); GTx (Inst); ImClone Systems (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Dendreon; Janssen; Medivation
 
Bernard H. Bochner
No Relationships to Disclose
 
Eila C. Skinner
No Relationships to Disclose
 
Tracy Downs
No Relationships to Disclose
 
Anne E Kiltie
No Relationships to Disclose
 
Dean F. Bajorin
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Genentech; Merck; Novartis; Roche; Roche/Genentech
Research Funding - Amgen (Inst); dendreon (Inst); Genentech/Roche (Inst); Merck; Novartis (Inst)
Travel, Accommodations, Expenses - Merck; Roche/Genentech
 
Khurshid Guru
No Relationships to Disclose
 
William U. Shipley
Stock and Other Ownership Interests - Pfizer
 
Gary D. Steinberg
No Relationships to Disclose
 
Noah M. Hahn
Honoraria - D3 Oncology Solutions
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Medivation; Merck; Oncogenex
Research Funding - Abbott Laboratories (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Dendreon (Inst); Genentech/Roche (Inst); Merck (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Srikala S. Sridhar
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Research Funding - Sanofi (Inst)